Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine liposome local infiltration vs pudendal nerve block for postoperative hemorrhoid pain
ChiCTR2400090010Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in hemorrhoid (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Postoperative pain score. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
hemorrhoid
Beyond the preview
Go deeper on ChiCTR2400090010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400090010.